Citations

Mayo Clinic

Showing 10 of 108602 citations.

Single Versus Multidrug Regimen for Surgical Infection Prophylaxis in Left Ventricular Assist Device Implantation
Aburjania, Nana , Ertmer, Brennan, Farid, Saira, Berg, Melody L. , Nienaber, Juhsien J. C., Tchantchaleishvili, Vakhtang , Stulak, John M., Sohail, M. Rizwan , Ertmer, Brennan M, Sohail, Muhammad R, Sohail, M Rizwan , Tchantchaleishvili, Vakhtang , Baddour, Larry M.

ASAIO Journal | November 3, 2017 | Volume: 64 | Issue: 6 | Pages: 735-740

10.1097/mat.0000000000000710 | PMID 29095735 Get It

Infection is a serious complication of left ventricular assist device (LVAD) therapy. However, an optimal antimicrobial surgical infection prophylaxis (SIP) regimen for LVAD implantation is not well established. We retrospectively reviewed all adults who underwent continuous-flow LVAD implantation from February 2007 to March 2015 at Mayo Clinic Rochester. Left ventricular assist device infection (LVADI) was defined using criteria published by the International Society for Heart and Lung Transplant. Patients excluded from the analysis included those who did not have HeartMate II or HeartWare device, patients with incomplete documentation of SIP, and those with an actively treated infection at the time of LVAD implantation. We compared risk of LVAD-specific and LVAD-related infections and all-cause mortality between SIP regimens at postoperative day 90 and 1 year using Kaplan–Meier time-to-event analyses. During study period, 239 adults underwent continuous-flow LVAD implantation at our institution where 199 patients received single-drug and 40 received multidrug SIP regimen. Median patient age was 62 years. Left ventricular assist device infection occurred in three patients (1.5%) in the single-drug group versus two patients (5.0%) in the multidrug group at 90 days (p = 0.4). There was no difference in infection-free (p = 0.4) and overall survival (p = 0.9) between two groups at 1 year. In conclusion, there was no clear benefit of using multidrug regimen as it did not impact infection-free survival or all-cause mortality compared with single-drug regimen. Prospective clinical trials are needed to further define the optimal SIP regimen for LVAD implantation.
Left Ventricular Assist Device Infections: A Systematic Review
O’Horo, John C. , Saleh, Omar Abu , Stulak, John M., Wilhelm, Mark , Sohail, M. Rizwan , Abu Saleh, Omar M, Wilhelm, Mark P, Sohail, M Rizwan , O'Horo, John C , Baddour, Larry M.

ASAIO Journal | November 3, 2017 | Volume: 64 | Issue: 3 | Pages: 287-294

10.1097/mat.0000000000000684 | PMID 29095732 Get It

Left ventricular assist devices (LVADs) are becoming a more frequent life-support intervention. Gaining an understanding of risk factors for infection and management strategies is important for treating these patients. We conducted a systematic review and meta-analysis of studies describing infections in continuous-flow LVADs. We evaluated incidence, risk factors, associated microorganisms, and outcomes by type of device and patient characteristics. Our search identified 90 distinct studies that reported LVAD infections and outcomes. Younger age and higher body mass index were associated with higher rates of LVAD infections. Driveline infections were the most common infection reported and the easiest to treat with fewest long-term consequences. Bloodstream infections were not reported as often, but they were associated with stroke and mortality. Treatment strategies varied and did not show a consistent best approach. LVAD infections are a significant cause of morbidity and mortality in LVAD patients. Most research comes from secondary analyses of other LVAD studies. The lack of infection-oriented research leaves several areas understudied. In particular, bloodstream infections in this population merit further research. Providers need more research studies to make evidence-based decisions about the prevention and treatment of LVAD infections.
Can Lung Ultrasound Be the First-Line Tool for Evaluation of Intraoperative Hypoxemia?
Díaz‐Gómez, José L. , Ratzlaff, Robert A. , Via, Gabriele , Torp, Klaus D. , Ramakrishna, Harish , Díaz-Gómez, José L , Renew, J. Ross

Anesthesia & Analgesia | November 3, 2017 | Volume: 126 | Issue: 5 | Pages: 1769-1773

10.1213/ane.0000000000002578 | PMID 29099431 Get It

The Society for Obstetric Anesthesia and Perinatology Consensus Statement on the Anesthetic Management of Pregnant and Postpartum Women Receiving Thromboprophylaxis or Higher Dose Anticoagulants
Leffert, Lisa , Butwick, Alexander J. , Bates, Shannon M. , Friedman, Alex, Horlocker, Terese T. , Houle, Timothy T. , Arendt, Katherine, Horlocker, Terese, Carvalho, Brendan , Arendt, Katherine W. , Landau, Ruth

Anesthesia & Analgesia | November 3, 2017 | Volume: 126 | Issue: 3 | Pages: 928-944

10.1213/ane.0000000000002530 | PMID 29099429 Get It

Venous thromboembolism is recognized as a leading cause of maternal death in the United States. Thromboprophylaxis has been highlighted as a key preventive measure to reduce venous thromboembolism–related maternal deaths. However, the expanded use of thromboprophylaxis in obstetrics will have a major impact on the use and timing of neuraxial analgesia and anesthesia for women undergoing vaginal or cesarean delivery and other obstetric surgeries. Experts from the Society of Obstetric Anesthesia and Perinatology, the American Society of Regional Anesthesia, and hematology have collaborated to develop this comprehensive, pregnancy-specific consensus statement on neuraxial procedures in obstetric patients receiving thromboprophylaxis or higher dose anticoagulants. To date, none of the existing anesthesia societies’ recommendations have weighed the potential risks of neuraxial procedures in the presence of thromboprophylaxis, with the competing risks of general anesthesia with a potentially difficult airway, or maternal or fetal harm from avoidance or delayed neuraxial anesthesia. Furthermore, existing guidelines have not integrated the pharmacokinetics and pharmacodynamics of anticoagulants in the obstetric population. The goal of this consensus statement is to provide a practical guide of how to appropriately identify, prepare, and manage pregnant women receiving thromboprophylaxis or higher dose anticoagulants during the ante-, intra-, and postpartum periods. The tactics to facilitate multidisciplinary communication, evidence-based pharmacokinetic and spinal epidural hematoma data, and Decision Aids should help inform risk–benefit discussions with patients and facilitate shared decision making.
Whole Blood mRNA Expression-Based Prognosis of Metastatic Renal Cell Carcinoma
Giridhar, Karthik V. , Sosa, Carlos, Sanhueza, Cristobal T., Dalpiaz, Candace Lee, Costello, Brian A. , Pitot, Henry C., Dronca, Roxana , Ertz, Donna, Cheville, John C. , Donkena, Krishna Vanaja, Sosa, Carlos P., Hillman, David W. , Sanhueza, Cristobal, Dalpiaz, Candace L, Quevedo, Fernando J, Dronca, Roxana S., Kohli, Manish , Giridhar, Karthik V , Quevedo, Fernando

International Journal of Molecular Sciences | November 3, 2017 | Volume: 18 | Issue: 11 | Pages: 2326

10.3390/ijms18112326 | PMID 29099775 Get It

The Memorial Sloan Kettering Cancer Center (MSKCC) prognostic score is based on clinical parameters. We analyzed whole blood mRNA expression in metastatic clear cell renal cell carcinoma (mCCRCC) patients and compared it to the MSKCC score for predicting overall survival. In a discovery set of 19 patients with mRCC, we performed whole transcriptome RNA sequencing and selected eighteen candidate genes for further evaluation based on associations with overall survival and statistical significance. In an independent validation of set of 47 patients with mCCRCC, transcript expression of the 18 candidate genes were quantified using a customized NanoString probeset. Cox regression multivariate analysis confirmed that two of the candidate genes were significantly associated with overall survival. Higher expression of BAG1 [hazard ratio (HR) of 0.14, p < 0.0001, 95% confidence interval (CI) 0.04–0.36] and NOP56 (HR 0.13, p < 0.0001, 95% CI 0.05–0.34) were associated with better prognosis. A prognostic model incorporating expression of BAG1 and NOP56 into the MSKCC score improved prognostication significantly over a model using the MSKCC prognostic score only (p < 0.0001). Prognostic value of using whole blood mRNA gene profiling in mCCRCC is feasible and should be prospectively confirmed in larger studies.
How guiding coalitions promote positive culture change in hospitals: a longitudinal mixed methods interventional study
Bradley, Elizabeth H. , Brewster, Amanda L. , McNatt, Zahirah , Linnander, Erika , Cherlin, Emily , Fosburgh, Heather, Ting, Henry H. , Curry, Leslie , Fosburgh, Heather

BMJ Quality & Safety | November 3, 2017 | Volume: 27 | Issue: 3 | Pages: 218-225

10.1136/bmjqs-2017-006574 | PMID 29101290 Get It

Background Quality collaboratives are widely endorsed as a potentially effective method for translating and spreading best practices for acute myocardial infarction (AMI) care. Nevertheless, hospital success in improving performance through participation in collaboratives varies markedly. We sought to understand what distinguished hospitals that succeeded in shifting culture and reducing 30-day risk-standardised mortality rate (RSMR) after AMI through their participation in the Leadership Saves Lives (LSL) collaborative. Procedures We conducted a longitudinal, mixed methods intervention study of 10 hospitals over a 2-year period; data included surveys of 223 individuals (response rates 83%–94% depending on wave) and 393 in-depth interviews with clinical and management staff most engaged with the LSL intervention in the 10 hospitals. We measured change in culture and RSMR, and key aspects of working related to team membership, turnover, level of participation and approaches to conflict management. Main findings The six hospitals that experienced substantial culture change and greater reductions in RSMR demonstrated distinctions in: (1) effective inclusion of staff from different disciplines and levels in the organisational hierarchy in the team guiding improvement efforts (referred to as the ‘guiding coalition’ in each hospital); (2) authentic participation in the work of the guiding coalition; and (3) distinct patterns of managing conflict. Guiding coalition size and turnover were not associated with success (p values>0.05). In the six hospitals that experienced substantial positive culture change, staff indicated that the LSL learnings were already being applied to other improvement efforts. Principal conclusions Hospitals that were most successful in a national quality collaborative to shift hospital culture and reduce RSMR showed distinct patterns in membership diversity, authentic participation and capacity for conflict management.
Influencing organisational culture to improve hospital performance in care of patients with acute myocardial infarction: a mixed-methods intervention study
Curry, Leslie , Brault, Marie A. , Linnander, Erika , McNatt, Zahirah , Brewster, Amanda L. , Cherlin, Emily , Flieger, Signe Peterson , Ting, Henry H. , Bradley, Elizabeth H.

BMJ Quality & Safety | November 3, 2017 | Volume: 27 | Issue: 3 | Pages: 207-217

10.1136/bmjqs-2017-006989 | PMID 29101292 Get It

Background Hospital organisational culture affects patient outcomes including mortality rates for patients with acute myocardial infarction; however, little is known about whether and how culture can be positively influenced. Methods This is a 2-year, mixed-methods interventional study in 10 US hospitals to foster improvements in five domains of organisational culture: (1) learning environment, (2) senior management support, (3) psychological safety, (4) commitment to the organisation and (5) time for improvement. Outcomes were change in culture, uptake of five strategies associated with lower risk-standardised mortality rates (RSMR) and RSMR. Measures included a validated survey at baseline and at 12 and 24 months (n=223; average response rate 88%); in-depth interviews (n=393 interviews with 197 staff); and RSMR data from the Centers for Medicare and Medicaid Services. Results We observed significant changes (p<0.05) in culture between baseline and 24 months in the full sample, particularly in learning environment (p<0.001) and senior management support (p<0.001). Qualitative data indicated substantial shifts in these domains as well as psychological safety. Six of the 10 hospitals achieved substantial improvements in culture, and four made less progress. The use of evidence-based strategies also increased significantly (per hospital average of 2.4 strategies at baseline to 3.9 strategies at 24 months; p<0.05). The six hospitals that demonstrated substantial shifts in culture also experienced significantly greater reductions in RSMR than the four hospitals that did not shift culture (reduced RSMR by 1.07 percentage points vs 0.23 percentage points; p=0.03) between 2011–2014 and 2012–2015. Conclusions Investing in strategies to foster an organisational culture that supports high performance may help hospitals in their efforts to improve clinical outcomes.
Pulmonary arteriovenous extracorporeal membrane oxygenation to avoid pulmonary overflow during total artificial heart implantation
Tchantchaleishvili, Vakhtang , Luc, Jessica G.Y. , Sagebin, Fabio, Massey, H. Todd , Tchantchaleishvili, Vakhtang , Wong, Joshua K.

The International Journal of Artificial Organs | November 3, 2017 | Volume: 41 | Issue: 1 | Pages: 66-68

10.5301/ijao.5000655 | PMID 29099541 Get It

Total artificial hearts (TAH) can be used as a bridge to transplant or, occasionally, as destination therapy for patients with severe biventricular dysfunction. Not infrequently TAHs are placed in patients with severe low flow states, in which the lungs of these patients are unable to adjust rapidly to the “normal” right ventricular output of a TAH. These patients may develop variable degrees of pulmonary edema secondary to stress failure of the pulmonary capillaries requiring increased respiratory support, which can occasionally be fatal. In this “how to do it” article, we describe the technique for a pulmonary arteriovenous extracorporeal membrane oxygenation with TAH to avoid sudden pulmonary overflow and gradually expose the lungs to increasing flow.
Dual antiplatelet therapy in aneurysmal subarachnoid hemorrhage: association with reduced risk of clinical vasospasm and delayed cerebral ischemia
Nagahama, Yasunori , Allan, Lauren , Nakagawa, Daichi , Starke, Robert M. , Chalouhi, Nohra , Brown, Robert D., Derdeyn, Colin P. , Leira, Enrique C. , Chimowitz, Marc I. , Torner, James C., Hasan, David , Torner, James C. , Zanaty, Mario , Jabbour, Pascal , Broderick, Joseph P. , Derdeyn, Colin P

Journal of Neurosurgery | November 3, 2017 | Volume: 129 | Issue: 3 | Pages: 702-710

10.3171/2017.5.jns17831 | PMID 29099296 Get It

OBJECTIVE Clinical vasospasm and delayed cerebral ischemia (DCI) are devastating complications of aneurysmal subarachnoid hemorrhage (aSAH). Several theories involving platelet activation have been postulated as potential explanations of the development of clinical vasospasm and DCI. However, the effects of dual antiplatelet therapy (DAPT; aspirin and clopidogrel) on clinical vasospasm and DCI have not been previously investigated. The objective of this study was to evaluate the effects of DAPT on clinical vasospasm and DCI in aSAH patients. METHODS Analysis of patients treated for aSAH during the period from July 2009 to April 2014 was performed in a single-institution retrospective study. Patients were divided into 2 groups: patients who underwent stent-assisted coiling or placement of flow diverters requiring DAPT (DAPT group) and patients who underwent coiling only without DAPT (control group). The frequency of symptomatic clinical vasospasm and DCI and of hemorrhagic complications was compared between the 2 groups, utilizing univariate and multivariate logistic regression. RESULTS Of 312 aSAH patients considered for this study, 161 met the criteria for inclusion and were included in the analysis (85 patients in the DAPT group and 76 patients in the control group). The risks of clinical vasospasm (OR 0.244, CI 95% 0.097–0.615, p = 0.003) and DCI (OR 0.056, CI 95% 0.01–0.318, p = 0.001) were significantly lower in patients receiving DAPT. The rates of hemorrhagic complications associated with placement of external ventricular drains and ventriculoperitoneal shunts were similar in both groups (4% vs 2%, p = 0.9). CONCLUSIONS The use of DAPT was associated with a lower risk of clinical vasospasm and DCI in patients treated for aSAH, without an increased risk of hemorrhagic complications.